Long-term safety of a non-chlorofluorocarbon-containing triamcinolone acetonide inhalation aerosol in patients with asthma

Journal of Asthma

Volumn 37, Issue 2, 2000, Pages 145-152

  Nelson, Harold S ^a   Kane, Robert E ^b   Petillo, John ^b   Banerji, Donald ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b SANOFI   (France)

Author keywords

Asthma; HFA; Inhaled corticosteroid; Safety; Triamcinolone acetonide

Indexed keywords

CHLOROFLUOROCARBON; NORFLURANE; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AEROSOL; AGED; ARTICLE; ASTHMA; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG FORMULATION; DRUG SAFETY; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME;

EID: 0034057292     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770900009055437     Document Type: Article

References (10)

1. Harrison LI, Donnell D, Simmons JL, et al: Twenty-eight day double-blind study of an HFA-134a inhalation aerosol system in healthy subjects. J Pharm Pharmacol 48:596 (1996).
2. United States Pharmacopeial Convention: Dosage unit sampling for metered-dose inhalers. Pharmacopeial Forum 24:6940 (1998).
3. Jacobson K, Kane RE, Banerji D, Azmacort HFA Clinical Study Group: Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Ann Allergy Asthma Immunol 83:327 (1999).
4. Welch M, Kane RE, Donald Banerji D, Azmacort® HFA Study Group: Triamcinolone acetonide inhalation aerosol in the treatment of moderate persistent asthma; comparison of products using a chlorofluorocarbon and a non-chlorofluorocarbon propellant. Chest 116:1304 (1999).
5. Klein BEK, Klein R, Linton KLP: Prevalence of age-related lens opacities in a population. The Beaver Dam Study. Ophthalmology 99:546 (1992).
6. Sperduto RD, Seigel D: Senile lens and senile macular changes in a population-based sample. Am J Ophthalmol 90:86 (1980).
7. Weale RA: Inter-ethnic risk ratios for different types of cataract. Ophthalmol Res 27:214 (1995).
8. Urban RC Jr, Cotlier E: Corticosteroid-induced cataracts. Surv Ophthalmol 31:102 (1986).
9. Cumming RG, Mithcel P, Leeder SR: Use of inhaled corticosteroids and the risk of cataract. N Engl J Med 337:8 (1997).
10. Garbe E, Suissa S, LeLorier J: Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 280:539 (1998).